187 related articles for article (PubMed ID: 30099368)
1. Evaluating Antiretroviral Therapy Initiation in HIV-Associated Malignancy: Is There Enough Evidence to Inform Clinical Guidelines?
Oseso LN; Chiao EY; Bender Ignacio RA
J Natl Compr Canc Netw; 2018 Aug; 16(8):927-932. PubMed ID: 30099368
[No Abstract] [Full Text] [Related]
2. Cancer in People Living With HIV, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.
Reid E; Suneja G; Ambinder RF; Ard K; Baiocchi R; Barta SK; Carchman E; Cohen A; Gupta N; Johung KL; Klopp A; LaCasce AS; Lin C; Makarova-Rusher OV; Mehta A; Menon MP; Morgan D; Nathwani N; Noy A; Palella F; Ratner L; Rizza S; Rudek MA; Taylor J; Tomlinson B; Wang CJ; Dwyer MA; Freedman-Cass DA
J Natl Compr Canc Netw; 2018 Aug; 16(8):986-1017. PubMed ID: 30099375
[TBL] [Abstract][Full Text] [Related]
3. Drug Interactions in the Treatment of Malignancy in HIV-Infected Patients.
Welz T; Wyen C; Hensel M
Oncol Res Treat; 2017; 40(3):120-127. PubMed ID: 28253501
[TBL] [Abstract][Full Text] [Related]
4. New NCCN Guidelines: Cancer Management in People Living With HIV.
Suneja G
J Natl Compr Canc Netw; 2018 May; 16(5S):597-599. PubMed ID: 29784735
[TBL] [Abstract][Full Text] [Related]
5. The role of nonrandomized trials in the evaluation of oncology drugs.
Simon R; Blumenthal GM; Rothenberg ML; Sommer J; Roberts SA; Armstrong DK; LaVange LM; Pazdur R
Clin Pharmacol Ther; 2015 May; 97(5):502-7. PubMed ID: 25676488
[TBL] [Abstract][Full Text] [Related]
6. Therapies. Confronting the limits of success.
Cohen J
Science; 2002 Jun; 296(5577):2320-4. PubMed ID: 12089422
[No Abstract] [Full Text] [Related]
7. Special considerations regarding antiretroviral therapy and infection prophylaxis in the HIV-infected individual with cancer.
Sparano JA; Kalkut G
Cancer Treat Res; 2001; 104():347-66. PubMed ID: 11191134
[No Abstract] [Full Text] [Related]
8. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
Chang LW; Harris J; Humphreys E
Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
[TBL] [Abstract][Full Text] [Related]
9. Reflections on ethical concerns arising from the incorporation of results of randomized trials of antineoplastic therapy into routine clinical practice.
Markman M
Cancer Invest; 2005; 23(8):735-40. PubMed ID: 16377592
[TBL] [Abstract][Full Text] [Related]
10. On antiretroviral guidelines and evidence based medicine.
Tebas P
Enferm Infecc Microbiol Clin; 2002; 20(6):241-3. PubMed ID: 12084353
[No Abstract] [Full Text] [Related]
11. Appendix D. Summary of Evidence-based Guideline for CLINICIANS: ANTIEPILEPTIC DRUG SELECTION FOR PEOPLE WITH HIV/AIDS.
Continuum (Minneap Minn); 2016 Feb; 22(1 Epilepsy):287-8. PubMed ID: 26844747
[No Abstract] [Full Text] [Related]
12. Leveraging Cancer Therapeutics for the HIV Cure Agenda: Current Status and Future Directions.
Polizzotto MN; Chen G; Tressler RL; Godfrey C
Drugs; 2015 Sep; 75(13):1447-59. PubMed ID: 26224205
[TBL] [Abstract][Full Text] [Related]
13. Infection prophylaxis and antiretroviral therapy in patients with HIV infection and malignancy.
Sparano JA; Sarta C
Curr Opin Oncol; 1996 Sep; 8(5):392-9. PubMed ID: 8914806
[TBL] [Abstract][Full Text] [Related]
14. From CD4-Based Initiation to Treating All HIV-Infected Adults Immediately: An Evidence-Based Meta-analysis.
Song A; Liu X; Huang X; Meyers K; Oh DY; Hou J; Xia W; Su B; Wang N; Lu X; Xia H; Yang X; Chen H; Wu H
Front Immunol; 2018; 9():212. PubMed ID: 29487595
[TBL] [Abstract][Full Text] [Related]
15. [HIV viral dynamic after antiretroviral treatment initiation: is a rapid decay a good pronostic?].
Delaugerre C
Pathol Biol (Paris); 2010 Dec; 58(6):403-5. PubMed ID: 19481371
[No Abstract] [Full Text] [Related]
16. [Clinical practice guidelines for the adverse events in medical oncology].
Isobe T; Hayashi M; Tsubata Y
Nihon Rinsho; 2015 Feb; 73 Suppl 2():45-50. PubMed ID: 25831722
[No Abstract] [Full Text] [Related]
17. Is early antiretroviral therapy initiation useful in HIV(+) adults without co-infections?
Chauriye V; Monsalve X
Medwave; 2015 Dec; 15 Suppl 3():e6326. PubMed ID: 26639366
[TBL] [Abstract][Full Text] [Related]
18. Treatment comparisons in HIV infection: the benefits and limitations of observational cohort studies.
Sabin CA; Phillips AN
J Antimicrob Chemother; 2001 Apr; 47(4):371-5. PubMed ID: 11266407
[No Abstract] [Full Text] [Related]
19. Antiretroviral update: recent advances expand options for patients with HIV.
Santhanam H; Goins M
Adv Nurse Pract; 2004 Nov; 12(11):53-4, 56. PubMed ID: 15559568
[No Abstract] [Full Text] [Related]
20. Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2015.
Antinori A; Marcotullio S; Andreoni M; Chirianni A; d'Arminio Monforte A; Di Biagio A; Galli M; Mazzotta F; Mussini C; Puoti M; Lazzarin A;
New Microbiol; 2016 Apr; 39(2):93-109. PubMed ID: 27196547
[No Abstract] [Full Text] [Related]
[Next] [New Search]
